Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (43)
Leukemia (30)
British Journal of Cancer (11)
Nature Communications (5)
Nature (5)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (98)
Correspondence (6)
Reviews (5)
Special Features (4)
Amendments and Corrections (3)
News & Views (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biotechnology
Cancer
Cell biology
Computational biology and bioinformatics
Developmental biology
Diseases
Drug discovery
Ecology
Genetics
Health care
Immunology
Medical research
Molecular biology
Oncology
Pathogenesis
Risk factors
Stem cells
Systems biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 118 results

Advanced filters: Author: J G Gribben Clear advanced filters

Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

Claude D. Gimmi
Briggs W. Morrison
Lee M. Nadler
Research01 Dec 1996
Nature Medicine

Volume: 2, P: 1367-1370
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10

R Dummer
F-Y Yue
G Burg
Research01 May 1998
British Journal of Cancer

Volume: 77, P: 1413-1419
A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene

Sarah Baxendale
Marcy E. MacDonald
Gillian P. Bates
Research01 Jun 1993
Nature Genetics

Volume: 4, P: 181-186
Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)

K Olsson
CJ Gerard
EG Hanania
Research03 Nov 1999
Leukemia

Volume: 13, P: 1833-1842
Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)

GA Martín-Henao
M Picón
J García
Research05 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 579-587
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia

L Sutton
K Maloum
J-L Binet
Research22 Oct 1998
Leukemia

Volume: 12, P: 1699-1707
High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR

L Perey
J Benhattar
S Leyvraz
ResearchOpen Access27 Nov 2001
British Journal of Cancer

Volume: 85, P: 1713-1721
Acquisition of epithelial plasticity in human chronic liver disease

Single-cell RNA sequencing and 3D imaging have revealed the cellular changes and structural reorganization that occur during the progression of human chronic liver disease and as the liver attempts to regenerate.

Christopher Gribben
Vasileios Galanakis
Ludovic Vallier
ResearchOpen Access22 May 2024
Nature

Volume: 630, P: 166-173
Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis

J Roy
C Ryckman
R Delage
Reviews24 Jul 1998
Leukemia

Volume: 12, P: 1026-1030
Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis

R Kanteti
KB Miller
DP Schenkein
Research08 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 473-481
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers

CH Weaver
L Schwartzberg
CD Buckner
Research01 Nov 1997
Bone Marrow Transplantation

Volume: 20, P: 753-760
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study

Ph Colombat
P Cornillet
N Milpied
Research20 Nov 2000
Bone Marrow Transplantation

Volume: 26, P: 971-977
Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease

R García
JM Hernández
JF San Miguel
Research01 Dec 1993
British Journal of Cancer

Volume: 68, P: 1227-1231
Heterogeneity within and among co-occurring foundation species increases biodiversity

Species interactions that can enhance habitat heterogeneity such as facilitation cascades of foundation species have been overlooked in biodiversity models. This study conducted 22 geographically distributed experiments in different ecosystems and biogeographical regions to assess the extent to which biodiversity is explained by three axes of habitat heterogeneity in facilitation cascades.

Mads S. Thomsen
Andrew H. Altieri
Gerhard Zotz
ResearchOpen Access31 Jan 2022
Nature Communications

Volume: 13, P: 1-9
Correction: Chronic lymphocytic leukaemia

Thomas J. Kipps
Freda K. Stevenson
Kanti Rai
Amendments and Corrections09 Feb 2017
Nature Reviews Disease Primers

Volume: 3, P: 1
Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker

LR Hiorns
J Nicholls
M Brada
Research01 Feb 1994
British Journal of Cancer

Volume: 69, P: 347-351
Autologous stem cell transplantation for poor prognosis Hodgkin’s disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group

A Sureda
R Mataix
A Domingo-Albós
Research01 Aug 1997
Bone Marrow Transplantation

Volume: 20, P: 283-288
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin’s lymphoma

CH Weaver
L Schwartzberg
CD Buckner
Research06 Mar 1998
Bone Marrow Transplantation

Volume: 21, P: 383-389
Growth dynamics in naturally progressing chronic lymphocytic leukaemia

Analysis of growth dynamics in a dataset from 107 patients with chronic lymphocytic leukaemia (CLL) reveals both exponential and logistic patterns of growth, which are associated with differences in genetic attributes and clinical outcomes.

Michaela Gruber
Ivana Bozic
Catherine J. Wu
Research29 May 2019
Nature

Volume: 570, P: 474-479
Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence

How the bone marrow microenvironment evolves during induction chemotherapy to facilitate acute lymphoblastic leukaemia (ALL) survival remains unclear. Here the authors show that adipocytes emergent during ALL therapy aid the survival of ALL cells through a restrictive effect on the ALL proteome.

Q. Heydt
C. Xintaropoulou
B. Patel
ResearchOpen Access17 Sept 2021
Nature Communications

Volume: 12, P: 1-18
Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd–25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies

R Munker
R Reibke
H J Kolb
News & Views18 Sept 2006
Bone Marrow Transplantation

Volume: 38, P: 593-607
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

Chronic lymphocytic leukemia has been studied using multiple levels of omics data. Here, the authors use exome sequencing, SNP, protein and gene expression data to identify distinct biologic tumor subtypes with heterogeneous prognostic impact after chemo- or immunochemotherapy.

Johannes Bloehdorn
Andrejs Braun
Daniel Mertens
ResearchOpen Access13 Sept 2021
Nature Communications

Volume: 12, P: 1-18
Secondary foundation species enhance biodiversity

Secondary foundation species, such as epiphytes, form structurally complex habitats on primary foundation species. A meta-analysis shows that they significantly enhance the abundance and richness of inhabitants compared to primary foundation species alone.

Mads S. Thomsen
Andrew H. Altieri
Gerhard Zotz
Research05 Mar 2018
Nature Ecology & Evolution

Volume: 2, P: 634-639
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years

AM Oza
TS Ganesan
TA Lister
Research01 Mar 1992
British Journal of Cancer

Volume: 65, P: 429-437
Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives

H Jackson
L Bacon
D Allen
Research01 Jul 1998
British Journal of Cancer

Volume: 78, P: 181-188
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT

Simona Iacobelli
Stefan Schönland
Nicolaus Kröger
ResearchOpen Access30 Jul 2025
Bone Marrow Transplantation

P: 1-8
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics

Boztug and colleagues identify an immunodeficient patient with a deficiency in the guanine-nucleotide-exchange factor RASGRP1. They find that human RASGRP1 is important for the function of T cells, B cells and NK cells and that it has a role in the regulation of the cytoskeleton.

Elisabeth Salzer
Deniz Cagdas
Kaan Boztug
Research24 Oct 2016
Nature Immunology

Volume: 17, P: 1352-1360
Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes

B Linke
I Bolz
M Kneba
Research01 Jul 1997
Leukemia

Volume: 11, P: 1055-1062
CD6⁺ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma

RJ Soiffer
AS Freedman
J Ritz
Research18 Jun 1998
Bone Marrow Transplantation

Volume: 21, P: 1177-1181
Cep55 promotes cytokinesis of neural progenitors but is dispensable for most mammalian cell divisions

In mammalian cell lines, Cep55 protein recruits the endosomal sorting complex required for transport (ESCRT) and promotes the completion of cell division. Here, the authors show that Cep55-knockout mice are viable and primary fibroblasts cultured in vitro divide in a Cep55 and ESCRT-independent way.

Antonio Tedeschi
Jorge Almagro
Mark Petronczki
ResearchOpen Access08 Apr 2020
Nature Communications

Volume: 11, P: 1-16
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial

A Brion
B Mahé
P Feugier
Research04 Jul 2011
Bone Marrow Transplantation

Volume: 47, P: 542-548
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins’s disease or non-Hodgkin’s lymphoma

O Fitoussi
D Simon
C Gisselbrecht
Research30 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 747-755
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Whole-genome sequencing of chronic lymphocytic leukemia from 485 patients identifies putative coding and noncoding drivers of disease. Genomically defined subgroups show distinct clinical and biological characteristics.

Pauline Robbe
Kate E. Ridout
Anna Schuh
ResearchOpen Access04 Nov 2022
Nature Genetics

Volume: 54, P: 1675-1689
Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1

WJR Hirst
A Buggins
GJ Mufti
Research01 Jul 1997
Gene Therapy

Volume: 4, P: 691-699
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

MD Caballero
V Rubio
JFSan Miguel
Research01 Sept 1997
Bone Marrow Transplantation

Volume: 20, P: 451-458
Molecular map of chronic lymphocytic leukemia and its impact on outcome

A genomic, transcriptomic and epigenomic analysis of chronic lymphocytic leukemia identifies genetic drivers and molecular subtypes associated with clinical outcomes.

Binyamin A. Knisbacher
Ziao Lin
Gad Getz
Research04 Aug 2022
Nature Genetics

Volume: 54, P: 1664-1674
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors

“Although aberrant promoter DNA hypermethylation is a hallmark of cancer, it is not clear whether it is sufficient to drive transformation. Here, the authors use CRISPR-dCas9 to perform hit-and-run epigenetic editing, which prevents senescence entry in primary breast cells from healthy donors.”

Emily A. Saunderson
Peter Stepper
Gabriella Ficz
ResearchOpen Access13 Nov 2017
Nature Communications

Volume: 8, P: 1-15
Autologous CD34⁺ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications

P Jindra
V Koza
M Švojgrová
Research23 Jul 1999
Bone Marrow Transplantation

Volume: 24, P: 215-217
Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation

S Mizuta
Y Ito
H Saito
Research30 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 777-784
β-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas

PWM Johnson
J Whelan
TA Lister
Research01 Apr 1993
British Journal of Cancer

Volume: 67, P: 792-797
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes

Fadimana Kaya
Findlay Bewicke-Copley
Ana Rio-Machin
ResearchOpen Access09 Apr 2025
Leukemia

Volume: 39, P: 1526-1531
Proof of principle for epitope-focused vaccine design

Computational protein design methods are used to generate new candidates for a human respiratory syncytial virus (RSV) vaccine; artificial protein scaffolds that mimic the structure of a RSV epitope are shown to induce RSV-specific neutralizing antibodies in macaques.

Bruno E. Correia
John T. Bates
William R. Schief
Research05 Feb 2014
Nature

Volume: 507, P: 201-206
Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma

J W Friedberg
H Kim
A S Freedman
Research16 Sept 2003
Bone Marrow Transplantation

Volume: 32, P: 681-686
The treatment of relapsed or refractory intermediate grade non-Hodgkin’s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon

J Gryn
E Johnson
J Goldberg
Research01 Feb 1997
Bone Marrow Transplantation

Volume: 19, P: 221-226
Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin’s lymphomas

L Xerri
E Devilard
J Plumas
Research07 Oct 1999
Leukemia

Volume: 13, P: 1548-1553
The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myeloma

RD Brown
E Yuen
D Joshua
Research01 Aug 1997
Leukemia

Volume: 11, P: 1312-1317
Expression of B7-2 (CD86) molecules by Reed–Sternberg cells of Hodgkin’s disease

SW Van Gool
J Delabie
JL Ceuppens
Research01 Jun 1997
Leukemia

Volume: 11, P: 846-851
The importance of CD34⁺/CD33⁻ cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue

BC Millar
JL Millar
D Catovsky
Research19 Aug 1998
Bone Marrow Transplantation

Volume: 22, P: 469-475
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

C Flotho
S Valcamonica
CM Niemeyer
Research27 Jan 1999
Leukemia

Volume: 13, P: 32-37
Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation

L Xerri
R Bouabdallah
F Birg
Research01 Jul 1998
British Journal of Cancer

Volume: 78, P: 225-232

Previous page
page 1
page 2
page 3
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited